CIK 0000818686 · Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972 (3) 914-8213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,242,786
- in 10 filings, $10.6M under 10b5-1 plans
Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-07 | Drape Eric Executive VP Global Operations | Grant or award · Restricted Share Units | +47,598 | 47,598 | ||
| 2023-02-07 | Dethlefs Sven EVP, North America Commercial | Grant or award · Restricted Share Units | +42,309 | 42,309 | ||
| 2023-02-07 | Daniell Richard Exec. VP, European Commercial | Grant or award · Restricted Share Units | +50,242 | 50,242 | ||
| 2022-11-04 | Zaks Tal Zvi Director | Option exercise | +12,205 | 12,222 | ||
| 2022-11-04 | Zaks Tal Zvi Director | Option exercise · Restricted Share Units | −12,205 | 0 | ||
| 2022-11-01 | Schultz Kare President and CEO | Option exercise | +116,389 | 1,542,471 | ||
| 2022-11-01 | Schultz Kare President and CEO | Option exercise · Restricted Share Units | −116,389 | 0 | ||
| 2022-08-22 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Sale | −55,500 | $10.07 | $559K | 9,376 |
| 2022-08-10 | Shani Eli EVP,Global Marketing&Portfolio | Option exercise | +1,581 | 19,741 | ||
| 2022-08-10 | Shani Eli EVP,Global Marketing&Portfolio | Option exercise · Restricted Share Units | −1,581 | 0 | ||
| 2022-08-04 | Zaks Tal Zvi Director | Grant or award · Restricted Share Units | +15,810 | 15,810 | ||
| 2022-08-04 | Vergis Janet S. Director | Grant or award · Restricted Share Units | +15,810 | 15,810 | ||
| 2022-08-04 | Satchi-Fainaro Ronit Director | Grant or award · Restricted Share Units | +15,810 | 15,810 | ||
| 2022-08-04 | Peres Nechemia Jacob Director | Grant or award · Restricted Share Units | +15,810 | 15,810 | ||
| 2022-08-04 | Nisen Perry Director | Grant or award · Restricted Share Units | +15,810 | 15,810 | ||
| 2022-08-04 | MIGNONE ROBERTO Director | Grant or award · Restricted Share Units | +15,810 | 15,810 | ||
| 2022-08-04 | LIEBERMAN GERALD M Director | Grant or award · Restricted Share Units | +15,810 | 15,810 | ||
| 2022-08-04 | Halfon Jean Michel Director | Grant or award · Restricted Share Units | +15,810 | 15,810 | ||
| 2022-08-04 | Elstein Amir Director | Grant or award · Restricted Share Units | +15,810 | 15,810 | ||
| 2022-08-04 | Crane Rosemary A Director | Grant or award · Restricted Share Units | +15,810 | 15,810 |
Page 34 of 76 · 1,517 trades